Stockreport

Atea Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Atea Pharmaceuticals, Inc. - common stock  (AVIR) 
PDF BOSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discov [Read more]